JPWO2019107440A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019107440A5
JPWO2019107440A5 JP2019557285A JP2019557285A JPWO2019107440A5 JP WO2019107440 A5 JPWO2019107440 A5 JP WO2019107440A5 JP 2019557285 A JP2019557285 A JP 2019557285A JP 2019557285 A JP2019557285 A JP 2019557285A JP WO2019107440 A5 JPWO2019107440 A5 JP WO2019107440A5
Authority
JP
Japan
Prior art keywords
cells
drug
differentiation
epidermal
promotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019557285A
Other languages
English (en)
Other versions
JP7471085B2 (ja
JPWO2019107440A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2018/043851 external-priority patent/WO2019107440A1/ja
Publication of JPWO2019107440A1 publication Critical patent/JPWO2019107440A1/ja
Publication of JPWO2019107440A5 publication Critical patent/JPWO2019107440A5/ja
Application granted granted Critical
Publication of JP7471085B2 publication Critical patent/JP7471085B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (4)

  1. 2-メタクリロイルオキシエチルホスホリルコリン基を有するコポリマー、アセンヤク抽出物、酢酸レチノール、及びシカクマメ抽出物からなる群から選択される少なくとも1種類の成分を含むコレステロール合成促進剤。
  2. 請求項1に記載のコレステロール合成促進剤を含む、表皮細胞の分化を促進するための組成物。
  3. 表皮細胞の分化を促進する薬剤をスクリーニングする方法であって、候補薬剤を培養細胞に作用させた場合に、該細胞のDHCR7遺伝子の発現を亢進させる薬剤を表皮細胞の分化を促進する薬剤として選定することを特徴とする方法。
  4. 前記培養細胞がヒト表皮角化細胞である、請求項3に記載の方法。
JP2019557285A 2017-11-30 2018-11-28 コレステロール合成促進剤 Active JP7471085B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017230166 2017-11-30
JP2017230166 2017-11-30
PCT/JP2018/043851 WO2019107440A1 (ja) 2017-11-30 2018-11-28 コレステロール合成促進剤

Publications (3)

Publication Number Publication Date
JPWO2019107440A1 JPWO2019107440A1 (ja) 2021-01-14
JPWO2019107440A5 true JPWO2019107440A5 (ja) 2022-01-31
JP7471085B2 JP7471085B2 (ja) 2024-04-19

Family

ID=66665228

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019557285A Active JP7471085B2 (ja) 2017-11-30 2018-11-28 コレステロール合成促進剤

Country Status (3)

Country Link
JP (1) JP7471085B2 (ja)
TW (1) TW201924673A (ja)
WO (1) WO2019107440A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110628737B (zh) * 2019-10-14 2022-06-07 南京农业大学 一个调控黄瓜矮化性状相关基因及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003292432A (ja) * 2002-04-04 2003-10-15 Noevir Co Ltd 皮膚外用剤
JP2004107243A (ja) * 2002-09-17 2004-04-08 Fancl Corp シワ及び/又はたるみ改善用キット
JP2005068073A (ja) 2003-08-25 2005-03-17 Takashi Fukazawa 目元用化粧料
JP4332458B2 (ja) 2004-03-30 2009-09-16 日油株式会社 皮膚化粧料
JP5311704B2 (ja) 2004-11-25 2013-10-09 日油株式会社 皮膚化粧料
FR2922763B1 (fr) 2007-10-31 2012-12-07 Oreal Composition cosmetique contenant un agent tenseur et un polymere acrylique.
JP2010143893A (ja) * 2008-12-22 2010-07-01 Nikko Chemical Co Ltd セリンプロテアーゼHtrA1及び/又はHtrA2の活性阻害剤
JP6071123B2 (ja) 2012-02-10 2017-02-01 株式会社 資生堂 水中油型乳化皮膚化粧料
KR101664025B1 (ko) * 2014-06-30 2016-10-10 (재) 경북천연염색산업연구원 천연 식물 추출물을 함유하는 화장료 조성물

Similar Documents

Publication Publication Date Title
JOP20200020B1 (ar) ميوتينات إنترليوكين-21 وطرق العلاج
JP2014158488A5 (ja)
EP4296278A3 (en) Non-human animals having a humanized cluster of differentiation 47 gene
WO2016014900A3 (en) Promoters derived from yarrowia lipolytica and arxula adeninivorans, and methods of use thereof
WO2016154579A3 (en) Crispr/cas-mediated gene conversion
WO2012056457A3 (en) Compositions and methods for activating expression by a specific endogenous mirna
BR112018007239A2 (pt) conjunto de válvula mitral
EP2636434A3 (en) Method and apparatus for presenting performances of gamers
WO2018007872A9 (en) Biomarkers for inflammatory bowel disease
MX2018009304A (es) Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares.
WO2012142116A3 (en) Identification and use of krp mutants in wheat
WO2017083852A8 (en) Methods for the treatment of corneal dystrophies
CA2835730C (en) Molecular markers in prostate cancer
WO2013177170A3 (en) Methods for drug screen using zebrafish model and the compounds screened thereform
JPWO2019107440A5 (ja)
WO2012056449A3 (en) Compositions and methods for specific cleavage of exogenous rna in a cell
MX2018007804A (es) Analogos de cortistatina y usos de los mismos.
WO2014063016A8 (en) Methods for generating genetically superior animals
WO2014117680A3 (zh) 外周血细胞TRPC6mRNA水平用于早期预测/诊断老年性痴呆
UY37544A (es) Anticuerpos humanizados contra cxcr3 con actividad mermadora y métodos de uso de los mismos
WO2012077898A3 (ko) 대사질환과 연관된 후각수용체 유전자 및 그의 용도
WO2017160694A3 (en) Compositions for providing vitamin d to the skin
CA2864237A1 (en) Methods and apparatuses harvesting, modifying and reimplantation of dermal micro -organs
RU2018147061A (ru) Способ обогащения культуры кератиноцитов человека стволовыми клетками эпидермиса
WO2009108021A3 (ko) 과색소침착성 피부 진단용 바이오 마커